Portfolio news 0

Storm Therapeutics

STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer

Quantum Dice

Quantum Dice and Astute Group announce global distribution partnership for QRNG chip products

Genomics

Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights

Microbiotica Ltd

Microbiotica announces the appointment of Dr Robert Tansley as Chief Medical Officer

Tissue Regenix Group plc

Tissue Regenix Group plc - CE & UKCA certification for OrthoPure® XT

Istesso Ltd

Istesso appoints Dr Mike Owen to Board of Directors

Quantum Dice

Quantum Dice launches Authorised Partner Programme to expand access to verifiable quantum randomness

AMSL Aero Ltd

AMSL Aero - First Australian Registered Liquid Hydrogen Tank Clears Runway For Zero-Emission Test Flights

Accelercomm Ltd

AccelerComm Secures $15m Funding to Speed Adoption of Technology for Space-Based 5G Networks to Deliver Universal Mobile Coverage

Iksuda Therapeutics Ltd

Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas